Meta tags:

Headings (most frequently used words):

ocra, for, center, rivkin, links, research, ovarian, cancer, the, has, joined, quick, patients, public, policy, about, suggested, expanding, through, partnership, related, topics, stay, informed, footer, support, resources, get, involved, family, summerun, president, ceo, audra, moran, named, crain, 2026, notable, leader, in, health, care, sponsors, nccn, guidelines, cervical, and, uterine, fda, approves, lifyorli, plus, abraxane, platinum, resistant, need, to, talk, free, genetic, testing, program, global, consortium, awards, inaugural, ai, accelerator, grant, announcing, new, become, monthly, donor, collaborates, with, operation, wipe, out,

Text of the page (most frequently used words):
transition (48), #cancer (43), and (38), for (33), ovarian (30), research (29), dropdownopen (24), opacity (24), transform (24), scale (24), 100 (24), the (23), ocra (23), about (18), enter (18), leave (18), gynecologic (16), start (14), support (13), center (12), class (12), ease (12), duration (12), end (12), resources (11), policy (10), woman (10), our (9), patients (9), more (9), program (9), out (9), get (8), public (8), rivkin (8), you (7), 2026 (7), alliance (7), events (7), cancers (7), care (7), impact (7), all (6), ways (6), with (6), treatment (6), has (6), null (6), cloak (6), show (6), pointer (6), none (6), 200 (6), absolute (6), left (6), flex (6), translate (6), read (5), international (5), partners (5), involved (5), uterine (5), find (5), prevention (5), peer (5), mentor (5), give (5), collaboration (4), sponsors (4), news (4), team (4), world (4), your (4), one (4), guidelines (4), cervical (4), information (4), community (4), here (4), risk (4), make (4), learn (4), genetic (4), testing (4), additional (4), volunteer (4), engage (4), advocate (4), current (4), staying (4), this (3), privacy (3), contact (3), financial (3), stewardship (3), press (3), links (3), leader (3), action (3), fda (3), continued (3), nccn (3), sponsor (3), patient (3), crain (3), new (3), health (3), related (3), steps (3), take (3), newly (3), diagnosed (3), joined (3), doctor (3), become (3), 190 (3), 197 (3), 196 (3), 195 (3), 185 (3), 175 (3), website (2), use (2), that (2), have (2), terms (2), donate (2), quick (2), fight (2), email (2), join (2), drug (2), lifyorli (2), abraxane (2), platinum (2), resistant (2), prior (2), april (2), proud (2), access (2), critical (2), audra (2), moran (2), president (2), ceo (2), been (2), notable (2), are (2), leading (2), supporting (2), families (2), family (2), help (2), cure (2), improve (2), education (2), global (2), connect (2), expanding (2), advancing (2), free (2), close (2), mission (2), share (2), photos (2), story (2), event (2), calendar (2), survivors (2), teaching (2), students (2), now (2), other (2), estate (2), planning (2), scientist (2), fundraise (2), honor (2), loved (2), donation (2), collaborative (2), corner (2), blog (2), priorities (2), symposium (2), researchers (2), prizes (2), grantees (2), results (2), partner (2), network (2), resource (2), directory (2), conference (2), clinical (2), trials (2), counseling (2), webinars (2), workshops (2), roundtables (2), connected (2), series (2), vulvar (2), vaginal (2), sarcoma (2), endometrial (2), caring (2), someone (2), finished (2), currently (2), menu (2), reach (2), accept, uses, cookies, ensure, best, experience, continuing, indicate, agree, 2024, inc, rights, reserved, advance, youtube, inspire, linkedin, instagram, facebook, against, footer, data, subscribe, address, updates, alerts, stay, informed, march, food, administration, approved, relacorilant, made, corcept, therapeutics, combination, nab, paclitaxel, adults, epithelial, fallopian, tube, primary, peritoneal, who, received, three, lines, including, avastin, bevacizumab, approval, follows, last, month, approves, plus, article, was, updated, reflect, release, 2025, believe, ensuring, clear, understandable, provides, wonderful, recognized, york, business, annual, recognition, spotlights, executives, whose, leadership, innovation, commitment, set, high, bar, field, honorees, selected, based, demonstrated, both, within, named, topics, organization, fighting, fronts, while, their, thousands, participants, ages, fitness, levels, seattle, seward, park, raise, awareness, fund, registration, opens, early, summerun, title, step, closer, there, many, lend, hand, lives, impacted, advocates, capitol, hill, diagnostic, safety, quality, members, having, helped, secure, billion, federal, funding, since, inception, awarded, than, 400, grants, invested, 140, million, initiatives, becoming, largest, charity, devoted, answer, questions, offer, essential, factors, navigating, life, beyond, gift, please, explore, below, tools, available, from, nonprofit, announce, combined, through, partnership, historic, unites, two, respected, organizations, committed, better, treatments, joins, home, signs, symptoms, suggested, search, screening, follow, collaborates, operation, wipe, today, promise, continuous, hope, monthly, donor, strengthening, voice, announcing, driven, efforts, personalize, consortium, awards, inaugural, accelerator, grant, direction, preventing, member, need, talk, open, main, skip, content,

Text of the page (random words):
the rivkin center has joined ocra ovarian cancer research alliance skip to content ovarian cancer research alliance open main menu for patients if dropdownopen 175 dropdownopen null 50 x cloak x show dropdownopen 175 class pointer events none dropdownopen 175 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 start here prevention risk newly diagnosed currently in treatment finished treatment caring for someone gynecologic cancers about gynecologic cancers ovarian cancer cervical cancer endometrial cancer uterine sarcoma vaginal cancer vulvar cancer need to talk connect with a member of our patient support team reach out support resources if dropdownopen 185 dropdownopen null 50 x cloak x show dropdownopen 185 class pointer events none dropdownopen 185 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 support resources woman to woman peer mentor program staying connected support series roundtables workshops and staying current webinars steps 1 1 counseling find a doctor genetic testing program about clinical trials additional resources international gynecologic cancer conference resource directory community partner network free genetic testing program a new direction in preventing ovarian cancer find out more research if dropdownopen 195 dropdownopen null 50 x cloak x show dropdownopen 195 class pointer events none dropdownopen 195 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 research impact results current grantees research prizes information for researchers rivkin ovarian cancer research symposium global ovarian cancer research consortium awards inaugural ai accelerator grant advancing ai driven efforts to personalize ovarian cancer care learn more center for public policy if dropdownopen 196 dropdownopen null 50 x cloak x show dropdownopen 196 class pointer events none dropdownopen 196 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 center for public policy impact priorities advocate s corner blog become an advocate partners gynecologic cancer collaborative announcing ocra s new center for public policy strengthening our voice and expanding our reach learn more get involved if dropdownopen 197 dropdownopen null 50 x cloak x show dropdownopen 197 class pointer events none dropdownopen 197 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 ways to give make a donation honor a loved one fundraise for ocra sponsor a scientist estate planning other ways to give volunteer engage volunteer engage take action now woman to woman peer mentor program survivors teaching students event calendar share your photos and story become a monthly donor make a promise of continuous hope and support give today about if dropdownopen 190 dropdownopen null 50 x cloak x show dropdownopen 190 class pointer events none dropdownopen 190 x transition enter transition ease out duration 200 x transition enter start opacity 0 transform scale 95 x transition enter end opacity 100 transform scale 100 x transition leave transition ease in duration 75 x transition leave start opacity 100 transform scale 100 x transition leave end opacity 0 transform scale 95 class absolute left 1 2 z 30 flex translate x 1 2 px 4 about ocra mission impact our team partners sponsors international collaboration additional about news financial stewardship press contact us ocra collaborates with operation wipe out supporting prevention screening and follow up care learn more donate ovarian cancer research alliance close menu for patients start here prevention risk newly diagnosed currently in treatment finished treatment caring for someone gynecologic cancers about gynecologic cancers ovarian cancer cervical cancer endometrial cancer uterine sarcoma vaginal cancer vulvar cancer support resources support resources woman to woman peer mentor program staying connected support series roundtables workshops and staying current webinars steps 1 1 counseling find a doctor genetic testing program about clinical trials additional resources international gynecologic cancer conference resource directory community partner network research research impact results current grantees research prizes information for researchers rivkin ovarian cancer research symposium center for public policy center for public policy impact priorities advocate s corner blog become an advocate partners gynecologic cancer collaborative get involved ways to give make a donation honor a loved one fundraise for ocra sponsor a scientist estate planning other ways to give volunteer engage volunteer engage take action now woman to woman peer mentor program survivors teaching students event calendar share your photos and story about about ocra mission impact our team partners sponsors international collaboration additional about news financial stewardship press contact us ovarian cancer research alliance close search suggested links quick links free genetic testing program prevention risk ovarian cancer signs symptoms woman to woman peer mentor program find a doctor home rivkin joins ocra the rivkin center has joined ocra the rivkin center has joined ocra this historic collaboration unites two respected organizations committed to advancing research for better treatments and a cure for ovarian cancer expanding research through partnership ovarian cancer research alliance ocra the world s leading ovarian and gynecologic cancer nonprofit is proud to announce that the rivkin center for ovarian cancer research has combined with ocra please explore the resources below to learn more about the support and tools available from ocra make a gift for patients for patients find essential information here about ovarian cancer prevention risk factors and steps to take if you ve been newly diagnosed in treatment or navigating life beyond support resources support resources ocra is here for you and your family to answer questions or connect you with resources to help you and offer support research research ocra has awarded more than 400 grants and invested 140 million in ovarian cancer and related gynecologic cancer research initiatives becoming the largest global charity devoted to ovarian and related gynecologic cancer research in the world center for public policy center for public policy ocra advocates on capitol hill to improve research and education drug and diagnostic safety and access to quality care for all members of the ovarian and gynecologic cancer community having helped secure 3 8 billion in federal research and education funding since inception get involved get involved help us get one step closer to a cure there are so many ways to lend a hand and improve the lives of patients and families impacted by ovarian and all gynecologic cancers no title ocra rivkin family summerun join thousands of participants of all ages and fitness levels at seattle s seward park to raise awareness and fund critical research for ovarian cancer registration opens in early april about about ocra is the leading organization in the world fighting ovarian and all gynecologic cancers on all fronts while supporting patients and their families related topics ocra president ceo audra moran named crain s 2026 notable leader in health care audra moran president and ceo of ovarian cancer research alliance ocra has been recognized as a crain s new york business 2026 notable leader in health care crain s annual recognition spotlights health care executives whose leadership innovation and community commitment set a high bar for the field honorees are selected based on demonstrated impact both within continued read more ocra sponsors nccn guidelines for cervical ovarian and uterine cancer patients this article was updated in april 2026 to reflect nccn s release of the 2026 guidelines for uterine cancer patients ocra is a proud sponsor of the 2026 patient guidelines for cervical cancer and uterine cancer and the 2025 patient guidelines for ovarian we believe ensuring access to clear understandable information is critical nccn provides wonderful continued read more fda approves lifyorli plus abraxane for platinum resistant ovarian cancer on march 25 2026 the u s food and drug administration fda approved lifyorli relacorilant made by corcept therapeutics in combination with abraxane nab paclitaxel for adults with platinum resistant epithelial ovarian fallopian tube or primary peritoneal cancer who have received one to three prior lines of treatment including prior avastin bevacizumab the approval follows last month s fda continued read more stay informed get email updates about research news action alerts and ways to join the fight email address subscribe we care about your data read our privacy policy footer the world s leader in the fight against gynecologic cancer facebook instagram x linkedin inspire youtube quick links donate to advance research for ovarian and gynecologic cancers for patients support resources research center for public policy get involved about about ocra our team press news events partners sponsors international collaboration financial stewardship contact us privacy terms 2024 2026 ovarian cancer research alliance inc all rights reserved our website uses cookies to ensure you get the best experience by continuing to use this website you indicate that you have read and agree to our terms of use and privacy policy accept